Fort Worth Startup Encore Vision to Sell to Pharmaceutical Giant Novartis

Pharmaceutical giant Novartis International is scooping up Fort Worth-based Encore Vision as it aims to introduce the market’s first topical treatment of the eye condition presbyopia.

Novartis, a Swiss public company that raked in $49.4 billion in revenue last year, announced the agreement Tuesday, but did not disclose the financial terms. Full Story

How North Texas Kickstarted the Telemedicine Revolution

Almost 15 years ago, a pair of entrepreneurs launched a telemedicine company in North Dallas that tried to monetize treating low acuity conditions over the phone. Teladoc built a physician base and targeted large employers, offering bridge services to employees when they couldn’t get into the doctor’s office for their cold or urinary tract infection or pink eye. Last year, Teladoc became the only telemedicine company to be publicly traded on the New York Stock Exchange. It posted annual revenue of $77 million in 2015, a year-over-year increase of 78 percent. And it’s also found itself in the middle of a national discussion on how telehealth services should be regulated. Just how much access is still safe for patients? Full Story

Teladoc Misses Earnings Projections In Q3, But Boosts Revenue, Visits, Subscriptions

The telemedicine provider recorded $32.4 million in revenue for the quarter, an increase of 62 percent compared to the same period in 2015. As is standard with the company, the revenue was primarily made up of subscription access fees ($27.8 million, up from $17 million in 2015) and visit fees ($4.6 million, up from $3 million). Full Story